Table 2 Correlation between MT1JP expression and intrahepatic cholangiocarcinoma patients’ clinicopathological characteristics
Variable | Category | No.of cases | χ2 | p value | |
|---|---|---|---|---|---|
MT1JP high expression | MT1JP low expression | ||||
(n = 15) | (n = 15) | ||||
Age | < 60 | 5 | 8 | 1.22172 | 0.26902 |
≥60 | 10 | 7 | |||
Sex | Male | 11 | 9 | 0.6 | 0.43858 |
Female | 4 | 6 | |||
Tumor size | ≤5 cm | 14 | 10 | 3.33333 | 0.06789 |
> 5 cm | 1 | 5 | |||
Histology differentiation | Well | 0 | 1 | 1.03448 | 0.30911 |
Moderate/Poor | 15 | 14 | |||
TNM stage | I-II | 15 | 7 | 10.9091 | 0.00096*** |
III-IV | 0 | 8 | |||
Lymph node metastasis | Present | 1 | 10 | 11.6268 | 0.00065*** |
Absent | 14 | 5 | |||
Distal metastasis | Present | 0 | 1 | 1.03448 | 0.30911 |
Absent | 15 | 14 | |||